
LPD officer honored for lifesaving efforts
Apr. 9—LARNED — At Monday's April meeting of the Larned City Council, a member of the Larned Police Department was recognized by the LPD and the council for lifesaving efforts in an incident occurring last year.
Prior to presenting LPD officer Samuel Sullivan with a uniform pin and a plaque designating him a recipient of the department's Lifesaving award, Larned Police Chief Lance Duft provided a history of the incident that occurred March 15, 2024.
"At 5:49 a.m., Officer Sullivan was dispatched to the 1000 block of Topeka Street in Larned for a report of a male subject experiencing difficulty breathing," Duft said.
Sullivan was joined by Pawnee County Sheriff's Deputy Nicholas Delaney, who located an adult male sitting on the front porch who was choking. "Without hesitation, Officer Sullivan and Deputy Delaney took immediate action in administration of the Heimlich Maneuver to clear the obstruction."
After the obstruction was dislodged, the officers placed the patient in a recovery position and monitored his condition, as he had collapsed from exhaustion. They then made contact with the incoming Emergency Medical Services team, to insure they reached the patient without delay. The individual was then transported to Pawnee Valley Community Hospital for further medical evaluation.
"Officer Sullivan's swift response, professionalism and dedication to service reflect the highest standards of the Larned Police Department," Duft noted. "His actions on that morning made the difference between life and death, and for that, we are proud to present him with the Lifesaving Award."
Larned City Council meeting at a glance
Here is a look at what the Larned City Council did Monday evening:
—In the consent agenda, authorized a request for transfer to Capital Improvement funds and approved Travis Hamrick as an appointment to the Community Corrections Board. City Financial Director Monica Steiner requested that $41,000 be transferred from the Electric Fund to capital improvement, to cover a $21,000 invoice to Falk Architects, Salina for the downtown streetscape project and $20,000 to cover the city's sidewalk program which had been expended.
—In public comments, rural Larned resident Felix Revello presented the council with additional information regarding the proposed ILS feed yard. Larned resident Tim Diambrosio expressed a concern about how information on city issues reaches residents.
—Larned Police Officer Samuel Sullivan was recognized for lifesaving actions in a March 15, 2024 incident.
—Larned energy consultant Greg Wright presented information regarding the Grand River Dam purchase power contract with the city. The city passed a resolution extending the current contract from May 1, 2026 through April 30, 2051.
—In new business, the council approved the reimbursement grant in the amount of $1,171,579 for airport lighting improvements with a local match of $58,579 to be split evenly with the city and the county.
—Approved the bid of $11,500 by H&H roofing for modification and installation of a new overhead door at the Larned Fire Station, contingent on engineer's approval.
—Tabled discussion of the purchase of a 75-foot ladder truck from the Great Bend Fire Station in the amount of $65,000. Discussion also included the construction of a storage building at the fire department's training site south of town to house the truck.
—Heard a presentation from Larned Police Chief Lance Duft regarding the Watchguard camera system in use by the department. Duft noted that the system was no longer supported and parts were no longer available, and recommended the city switch to a Motorola system with an upgrade to car and body cameras.
—Purchased the asphalt planer attachment in current rental use by the city street department from White Star, Wichita. The $8,000 in rent already expended would be applied to the purchase, leaving an amount of $29,099.
—Approved changes to city code as recommended by the Larned Planning Committee regarding fencing regulations and accessory buildings, approving the conditional use pending permit of shipping containers in commercially-zoned areas of the community and as a permitted use in industrial-zoned areas.
—Discussed chicken ordinances in use by the city. Councilmember Kim Barnes noted that ordinances governing the raising of chickens within the city limits have been discussed, approved and are currently in place.
—Following a 20-minute executive session on property acquisition, voted to purchase a vacant lot at 1401 Broadway, at an offered price of $12,000 with a $1,000 down payment.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Frost & Sullivan: iRegene Therapeutics Honored as "2025 Forbes China Leading Enterprises in Industry Development"
Shanghai, China--(Newsfile Corp. - June 8, 2025) - Recently, The "2025 Frost & Sullivan China Entrepreneurs Annual Conference and Forbes China Pioneer Innovators in Industry Development Selection Gala Evening of Honor," jointly organized by Frost & Sullivan and Forbes China, was successfully held at Regent Shanghai on The Bund. Amid the global trend of industrial innovation, the results of the "2025 Pioneer Innovators in Industry Development" selection jointly initiated by Forbes China and Frost & Sullivan were officially announced. iRegene Therapeutics was honored as one of Forbes China's 2025 Leading Enterprises in Industry Development. iRegene is pioneering the future of regenerative medicine with its AI-powered, chemically induced cell therapy platform. By combining cutting-edge technology, a robust R&D ecosystem, and a globally experienced leadership team, iRegene is redefining allogeneic therapies to make them safer, more effective, and broadly accessible. This recognition highlights iRegene's continued leadership in innovation and its commitment to transforming patient care through next-generation regenerative therapies. iRegene Therapeutics Honored as 2025 Forbes China Leading Enterprises in Industry Development Aroop Zutshi, Global Managing Partner and Executive Board Director of Frost & Sullivan, and Junyi Guo, General Manager of Business Operations at Forbes China, jointly presented the 2025 Forbes China Leading Enterprises in Industry Development award. Dr. Jun Wei, Chairman of iRegene Therapeutics, was invited to attend the gala. AI-Driven Chemical-Induced Cell Therapy: Reshaping the Future of Accessible Cell Therapy Since its establishment in 2017, iRegene Therapeutics has remained committed to addressing unmet clinical needs through the development of next-generation cell therapies. With a focus on chemically induced, universal cell therapy products, iRegene aims to deliver transformative treatments for patients with currently incurable diseases. iRegene Therapeutics has a proprietary, AI-based platform for screening chemical compounds to modify specific cellular functions. The platform leverages induced pluripotent stem cells (iPSCs) to enhance treatment potential. By combining compounds to form a chemically induced culture medium, the "AI+Chem" platform can efficiently and precisely reprogram or optimize a cell's fate and function, thereby enhancing the clinical capabilities of cell therapies. With a focus on the chemical induction system, iRegene has developed a comprehensive research and development (R&D) ecosystem and an international patent system that spans the industry. This ecosystem combines the discovery of 'cell fate determinants', the screening of chemical inducers and the validation of cellular function. The system does not use viral vector construction or transgenic methods; the straightforward CMC procedure is cost-efficient. Furthermore, cell transformation and functional optimization are entirely driven by the cells' natural genetic makeup. Transformation is synchronous under chemically enhanced regulation, eliminating the risk of genetic modification. iRegene's pioneering platform has been proven through the positive outcomes of the Phase I clinical trial. In addition, iRegene's executive team has an international perspective, with all members having successful overseas experience in their specialized fields. CEO Dr Wei Jun is a leading expert in regenerative medicine and the induced pluripotent stem cell (iPSC) technology, bringing strategic leadership to the company. Chief Medical Officer Dr Cai Meng has extensive experience taking innovative therapies from discovery through clinical development, while Chief Quality Officer Ren Xiang is a senior regulatory expert who provides solid support from IND approval to NDA clearance in China, the US, and other countries. Executive Vice President Emmanuel Montet, formerly Vice President of the Asia-Pacific region at Ipsen, now leads iRegene's global business development and international strategy. To accelerate global clinical translation and commercialization, iRegene places great emphasis on the philosophy of 'cooperation and mutual benefit'. At the end of 2021, iRegene entered a long-term collaboration with Danaher Corporation to co-develop next-generation platforms for clinical application. Under this partnership, Danaher will play an active role in developing multi-directional platforms for future iRegene Therapeutics projects. This will involve supplying advanced detection instruments and technical resources relating to life sciences research, the development of effective compounds and screening, multi-omics cell mechanism research, and multi-substance screening. Danaher will help iRegene Therapeutics to enhance the efficiency of platform construction and its ability to deliver practical solutions. Danaher will also support iRegene Therapeutics in developing distinctive, innovative drug pipelines and establishing a research and production base. This strategic cooperation has recently been elevated to the iRegene - Danaher Joint Innovation Center, which is the world's first "Joint Innovation Center for Chemically Induced Therapies and Microphysiology Systems". The center will focus on integrating artificial intelligence (AI)-driven chemically induced cell therapy R&D with microphysiology systems technology. It is committed to accelerating the clinical translation and application of innovative therapies, and providing patients globally with more precise and effective treatment solutions for diseases. Danaher will fully support iRegene Therapeutics' future planning and development, aiming to jointly advance innovative development in China's life sciences research. iRegene's breakthrough technology platform, strategic advantages and dedicated team have secured continuous support from several leading venture capital firms, with cumulative financing reaching nearly 400 million RMB (55.5 million USD). The company is advancing multiple programs through clinical development, targeting a win-win situation for its products and the capital markets alike, while providing patients around the world with next-generation chemically induced cell therapies that can genuinely reverse disease progression. About iRegene Therapeutics iRegene Therapeutics is a biotechnology company committed to becoming a global leader in universal chemical-induced cell therapy. As one of the first companies to harness AI and + chemical induction for the specific functional modification of cells, iRegene offers a safer, more scalable, and cost-effective alternative to traditional gene or cell therapies. Its pipeline targets diseases with high unmet need, including neurodegenerative disorders such as Parkinson's disease and blindness. Through pioneering science, strategic global partnerships, and a visionary leadership team, iRegene is reshaping the future of regenerative medicine - making advanced therapies accessible to patients worldwide. In August 2023, the NMPA approved the commencement of Phase I clinical trials for iRegene's first product: 'Human Dopaminergic Precursor Cell, NouvNeu001'. This product was developed using the 'AI+ Chem' platform. This made it the world's first chemically induced pluripotent stem cell (iPSC)-derived therapy to enter clinical trials. In June 2024, it was approved by the U.S. FDA for overseas clinical trials. Even more groundbreakingly, in March 2024, iRegene's 'Chemical Induction Platform' became the first system ever to be granted exemption by the FDA. The company's second product, NouvNeu003, which is intended for the treatment of early-onset Parkinson's disease, received NMPA approval in December 2023 and entered Phase I clinical trials. Both NouvNeu001 and NouvNeu003 have now completed Phase I trials. The Phase I results demonstrate good safety, tolerability, and encouraging efficacy in improving motor and non-motor symptoms. The Phase II trial for NouvNeu001 began in April 2025. In parallel, iRegene's first-in-class ophthalmic therapy, was granted Orphan Drug Designation (ODD) by the U.S. FDA in March 2024. Media Contact Company Name: Frost & SullivanWebsite: PR@ To view the source version of this press release, please visit Sign in to access your portfolio
Yahoo
5 days ago
- Yahoo
Level Plains officer saves two from burning car in ditch
DOTHAN, Ala (WDHN) — A Wiregrass police officer has been recognized for helping save two people from a fiery fate. 'The flames were so hot that I could feel the hair on my arms,' said Officer Brandon Bass. This week, the Level Plains Police Department honored Bass, a Patrol K-9 Officer, with the Life Saving Award. On May 24, Bass responded to a call on Highway 84 and Gladys Street after reports of a car running off the road and landing in a ditch. But when Officer Bass arrived on the scene, the situation was worse than imaginable. 'The car was bursting into flames. Multiple bystanders were yelling for help…There was two inside of the vehicle. At that time, we kind of take it as we don't know how many was in there. We gotta quick jump into action.' Thanks to the help of three Good Samaritans and a level plains reserve officer, Bass was able to remove the two people from the burning vehicle safely. With the potential of a serious injury or even death staring him in the eye, Bass said he didn't hesitate to help save those in the car. 'They say we train for a lot, but some stuff you just can't train for. You have to make that decision just that quickly. I would want someone to do what I did for my family.' According to Bass, the Life Saving Award is not just handed out regularly. Even though he did not jump into action with the thought of winning the award in mind, he did say it felt good to be recognized for his work. 'In law enforcement, we don't get recognized for what we do. We have a bad name and most people don't know what we deal with on a daily basis. To see that we're recognized for that, it actually shows the good that we do; that we do really care about people.' Bass explained that he was just extremely happy that both individuals were able to make it out safely. The Level Plains officer also wanted to extend his appreciation to the Henry County Sheriff's Department for their assistance in the rescue. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
5 days ago
- Yahoo
New Haven officials boosting awareness after 19 overdoses were reported in 4 days
NEW HAVEN, Conn. (WTNH) — In the city of New Haven, officials are activating a tier 2response after there were 19 overdoses in four days. Unfortunately, one person died but 18 others survived. Mobile overdose reduction clinic teaches Connecticut shoreline residents about prevention after recent overdose spike 'Tier 2 is 11 to 14 overdoses in 24 hours and then as you can imagine the higher number of overdoses would be a higher level of response,' Mayor Justin Elicker said. 'Above that, we would do robocall throughout the city to notify people. Tier 2 we use social media to engage our partners.' This comes just six months after police officers in New Haven started training and administering NARCAN. A big voice in the fight to get NARCAN into the hands of New Haven's police officers was Fiona Firine. Firine lost her 27-year-old son to a fentanyl overdose back in 2018 and since then, she's worked tirelessly to be an advocate for change. 'I'm so sad to hear that we have an uptick,' Firine said. 'I'm so grateful to hear those people were saved.' She said it took three years of fighting to get NARCAN into the police department, 'It had to go through a lot of different steps,' Firine said. 'It had to go through a lot of different barriers and ultimately it was decided the best way to get people to do it was to use these special tactical pouches that clip on.' Daniel Sullivan, supervisor of EMS for the New Haven Fire Department, said that generally, there are a large amount of overdoses in the city, but that 19 is high in a clustered time frame. Sullivan said administering NARCAN is imperative when it comes to saving someone's life during an overdose because it could prevent a cardiac arrest. 'With opioid overdoses, one of the biggest patient effects is it suppresses the respiratory system,' Sullivan said. Right now, DEA and intelligence units throughout New Haven have not been able to identify a common denominator or clear source, but one thing is clear: fentanyl is a common denominator. On Thursday city officials announced free CPR and AED training workshops that will be offered to residents at all five branches of the New Haven Free Public Library between June and November. Part of the workshops will also cover NARCAN administration. To register for a workshop, information can be found at Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.